Literature DB >> 20393178

Aggressive lymphomas.

Georg Lenz1, Louis M Staudt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393178      PMCID: PMC7316377          DOI: 10.1056/NEJMra0807082

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  99 in total

Review 1.  B cell antigen receptor signaling 101.

Authors:  Joseph M Dal Porto; Stephen B Gauld; Kevin T Merrell; David Mills; Aimee E Pugh-Bernard; John Cambier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

2.  The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.

Authors:  Weimin Ci; Jose M Polo; Leandro Cerchietti; Rita Shaknovich; Ling Wang; Shao Ning Yang; Kenny Ye; Pedro Farinha; Douglas E Horsman; Randy D Gascoyne; Olivier Elemento; Ari Melnick
Journal:  Blood       Date:  2009-03-23       Impact factor: 22.113

3.  Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.

Authors:  Takuma Aikawa; Jason Gunn; Suzanne M Spong; Stephen J Klaus; Murray Korc
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

4.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors:  Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

5.  Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.

Authors:  I S Lossos; A A Alizadeh; M B Eisen; W C Chan; P O Brown; D Botstein; L M Staudt; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.

Authors:  Jose M Polo; Tania Dell'Oso; Stella Maris Ranuncolo; Leandro Cerchietti; David Beck; Gustavo F Da Silva; Gilbert G Prive; Jonathan D Licht; Ari Melnick
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

7.  Control of inflammation, cytokine expression, and germinal center formation by BCL-6.

Authors:  A L Dent; A L Shaffer; X Yu; D Allman; L M Staudt
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

8.  Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.

Authors:  Ingo Melzner; Alexandra Juliana Bucur; Silke Brüderlein; Karola Dorsch; Cornelia Hasel; Thomas F E Barth; Frank Leithäuser; Peter Möller
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

9.  IRF4 addiction in multiple myeloma.

Authors:  Arthur L Shaffer; N C Tolga Emre; Laurence Lamy; Vu N Ngo; George Wright; Wenming Xiao; John Powell; Sandeep Dave; Xin Yu; Hong Zhao; Yuxin Zeng; Bangzheng Chen; Joshua Epstein; Louis M Staudt
Journal:  Nature       Date:  2008-06-22       Impact factor: 49.962

Review 10.  Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus.

Authors:  David Jung; Cosmas Giallourakis; Raul Mostoslavsky; Frederick W Alt
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

View more
  195 in total

1.  Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

Authors:  Sarah T Wilkinson; Kristie A Vanpatten; Diane R Fernandez; Patrick Brunhoeber; Karl E Garsha; Betty J Glinsmann-Gibson; Thomas M Grogan; Julie Teruya-Feldstein; Lisa M Rimsza
Journal:  Blood       Date:  2011-12-13       Impact factor: 22.113

2.  Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.

Authors:  Madhavi Challa-Malladi; Yen K Lieu; Olivia Califano; Antony B Holmes; Govind Bhagat; Vundavalli V Murty; David Dominguez-Sola; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

3.  Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.

Authors:  Jens G Lohr; Petar Stojanov; Michael S Lawrence; Daniel Auclair; Bjoern Chapuy; Carrie Sougnez; Peter Cruz-Gordillo; Birgit Knoechel; Yan W Asmann; Susan L Slager; Anne J Novak; Ahmet Dogan; Stephen M Ansell; Brian K Link; Lihua Zou; Joshua Gould; Gordon Saksena; Nicolas Stransky; Claudia Rangel-Escareño; Juan Carlos Fernandez-Lopez; Alfredo Hidalgo-Miranda; Jorge Melendez-Zajgla; Enrique Hernández-Lemus; Angela Schwarz-Cruz y Celis; Ivan Imaz-Rosshandler; Akinyemi I Ojesina; Joonil Jung; Chandra S Pedamallu; Eric S Lander; Thomas M Habermann; James R Cerhan; Margaret A Shipp; Gad Getz; Todd R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-17       Impact factor: 11.205

Review 4.  The future of B-cell lymphoma therapy: the B-cell receptor and its downstream pathways.

Authors:  Vaishalee P Kenkre; Brad S Kahl
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

5.  DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.

Authors:  Rita Shaknovich; Huimin Geng; Nathalie A Johnson; Lucas Tsikitas; Leandro Cerchietti; John M Greally; Randy D Gascoyne; Olivier Elemento; Ari Melnick
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

6.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

7.  Unexpected dissemination patterns in lymphoma progression revealed by serial imaging within a murine lymph node.

Authors:  Ken Ito; Bryan Ronain Smith; Natesh Parashurama; Joon-Kee Yoon; Si Yeol Song; Cornelius Miething; Parag Mallick; Scott Lowe; Sanjiv Sam Gambhir
Journal:  Cancer Res       Date:  2012-10-02       Impact factor: 12.701

8.  Pathophysiology and molecular aspects of diffuse large B-cell lymphoma.

Authors:  Gisele Rodrigues Gouveia; Sheila Aparecida Coelho Siqueira; Juliana Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 9.  Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

Authors:  Mark Roschewski; Louis M Staudt; Wyndham H Wilson
Journal:  Nat Rev Clin Oncol       Date:  2013-11-12       Impact factor: 66.675

10.  MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.

Authors:  D Jeong; J Kim; J Nam; H Sun; Y-H Lee; T-J Lee; R C T Aguiar; S-W Kim
Journal:  Leukemia       Date:  2015-04-27       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.